Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Eating too much selenium can cause bad breath, hair loss, and nail changes, with harmful effects starting at low daily doses.

Oxygen levels can drop during liver transplant if bypass pressures are too high, but other reasons should be checked first.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

People with hair loss have worse cholesterol levels, possibly linking hair loss to heart problems.

Korean patients with androgenetic alopecia may have a higher risk of heart-related health issues and could benefit from early heart screening and healthier lifestyles.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Hair loss may increase heart disease risk.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.